Internal Medicine, Pulmonary Disease · Mayaguez, PR
NPI
1023099231
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
55 de Diego E, Ste 401 Cpr Professional Building
Mayaguez, PR, 00680
Phone (787) 832-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,791
199 services
Medicare patients, 2024
33
Average age 76
Drug cost, 2024
$1.8M
17,257 prescriptions
Company payments, 2025
$202
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Armando O Cardona-Ramirez was code 99213 (office e&m - established), 55 times for 25 patients. In total Armando O Cardona-Ramirez billed 199 services in 10 codes, and Medicare paid $6,791.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 55 | 25 | $56.14 | $3,088 |
| 94375 Pulmonary Function Testing | Office | 30 | 20 | $27.29 | $819 |
| 94060 Pulmonary Function Testing | Office | 24 | 16 | $21.78 | $523 |
| 94729 Pulmonary Function Testing | Office | 15 | 15 | $43.99 | $660 |
| 94726 Pulmonary Function Testing | Office | 14 | 14 | $43.44 | $608 |
| 99203 Office E&M - New | Office | 11 | 11 | $84.45 | $929 |
By year: 2022 $5,929 for 156 services; 2023 $5,049 for 143 services; 2024 $6,791 for 199 services.
Medicare prescription drug claims, 2024
In 2024, the drug Armando O Cardona-Ramirez prescribed most often to Medicare patients was Levocetirizine Dihydrochloride, with 3,453 prescriptions and refills. In total Armando O Cardona-Ramirez wrote 17,257 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Generic | 3,453 | 3,487 | 718 | $32K |
| Montelukast Sodium Generic | 3,440 | 3,656 | 733 | $25K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 2,731 | 2,735 | 563 | $121K |
| Fluticasone Propionate Generic | 1,745 | 1,823 | 441 | $25K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 838 | 846 | 196 | $133K |
| Dexamethasone Generic | 670 | 670 | 394 | $11K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 652 | 670 | 153 | $181K |
| Albuterol Sulfate Generic | 451 | 451 | 282 | $5,687 |
| Prednisone Generic | 447 | 447 | 276 | $1,264 |
| Azelastine Hcl Generic | 256 | 372 | 96 | $5,226 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 251 | 260 | 66 | $65K |
| Breo Ellipta Fluticasone/Vilanterol | 245 | 251 | 50 | $100K |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 219 | 289 | 64 | $19K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 179 | 181 | 34 | $88K |
| Spiriva Respimat Tiotropium Bromide | 178 | 178 | 30 | $95K |
Brand drugs: - claims; generic drugs: 12,927 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Armando O Cardona-Ramirez $202 ($202 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $177.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $177 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.